Carrick Therapeutics is building an innovative portfolio of first-in-class treatments that target multiple mechanisms of the most aggressive forms of cancer. In doing so, we aim to have a major impact on the lives of patients with the greatest unmet need and transform the way that cancer is treated.
Funding Rounds (1) - $95MUpdate
Board Members and Advisors (3)Update
|Nov 14, 2016||cicplc.co.uk - CIC commits £19 million to six recent investments|
|Oct 3, 2016||PE HUB - Carrick Therapeutics raises $95 mln|
|Oct 3, 2016||FinSMEs - Carrick Therapeutics Secures $95M in Funding|
|Oct 3, 2016||Fierce Biotech - Oncology fledgling Carrick bags $95M Series A, names ex-AstraZeneca, Lilly exec as CEO|